These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27629855)

  • 1. The Role of Mast Cells in Alzheimer's Disease.
    Shaik-Dasthagirisaheb YB; Conti P
    Adv Clin Exp Med; 2016; 25(4):781-7. PubMed ID: 27629855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.
    Kempuraj D; Thangavel R; Selvakumar GP; Zaheer S; Ahmed ME; Raikwar SP; Zahoor H; Saeed D; Natteru PA; Iyer S; Zaheer A
    Front Cell Neurosci; 2017; 11():216. PubMed ID: 28790893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases.
    Sandhu JK; Kulka M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model.
    Kim KS; Kim HS; Park JM; Kim HW; Park MK; Lee HS; Lim DS; Lee TH; Chopp M; Moon J
    Neurobiol Aging; 2013 Oct; 34(10):2408-20. PubMed ID: 23623603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TNF in mast cell neuroinflammation and pain.
    Gu Y; Yang DK; Spinas E; Kritas SK; Saggini A; Caraffa A; Antinolfi P; Saggini R; Conti P
    J Biol Regul Homeost Agents; 2015; 29(4):787-91. PubMed ID: 26753638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model.
    Schmöle AC; Lundt R; Ternes S; Albayram Ö; Ulas T; Schultze JL; Bano D; Nicotera P; Alferink J; Zimmer A
    Neurobiol Aging; 2015 Feb; 36(2):710-9. PubMed ID: 25443294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
    Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
    Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mast cells in atherosclerosis: a classical inflammatory disease.
    Spinas E; Kritas SK; Saggini A; Mobili A; Caraffa A; Antinolfi P; Pantalone A; Tei M; Speziali A; Saggini R; Conti P
    Int J Immunopathol Pharmacol; 2014; 27(4):517-21. PubMed ID: 25572731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative effects of prostaglandins in Alzheimer's disease.
    Fattahi MJ; Mirshafiey A
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):50-60. PubMed ID: 23992456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
    Cai Z; Hussain MD; Yan LJ
    Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells in neuroinflammation and brain disorders.
    Hendriksen E; van Bergeijk D; Oosting RS; Redegeld FA
    Neurosci Biobehav Rev; 2017 Aug; 79():119-133. PubMed ID: 28499503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation Signaling Modulated by ASS234, a Multitarget Small Molecule for Alzheimer's Disease Therapy.
    Del Pino J; Marco-Contelles J; López-Muñoz F; Romero A; Ramos E
    ACS Chem Neurosci; 2018 Dec; 9(12):2880-2885. PubMed ID: 30048111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.
    Su F; Bai F; Zhang Z
    Neurosci Bull; 2016 Oct; 32(5):469-80. PubMed ID: 27568024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets.
    Casoli T; Di Stefano G; Balietti M; Solazzi M; Giorgetti B; Fattoretti P
    Biogerontology; 2010 Oct; 11(5):627-33. PubMed ID: 20454929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.
    Azizi G; Khannazer N; Mirshafiey A
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):415-25. PubMed ID: 24408754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.
    Avila-Muñoz E; Arias C
    Ageing Res Rev; 2014 Nov; 18():29-40. PubMed ID: 25078115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and chronic periodontitis: is there an association?
    Gaur S; Agnihotri R
    Geriatr Gerontol Int; 2015 Apr; 15(4):391-404. PubMed ID: 25511390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential release of mast cell mediators and the pathogenesis of inflammation.
    Theoharides TC; Kempuraj D; Tagen M; Conti P; Kalogeromitros D
    Immunol Rev; 2007 Jun; 217():65-78. PubMed ID: 17498052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cell and Astrocyte Hemichannels and Their Role in Alzheimer's Disease, ALS, and Harmful Stress Conditions.
    Harcha PA; Garcés P; Arredondo C; Fernández G; Sáez JC; van Zundert B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNAP-23 and syntaxin-3 are required for chemokine release by mature human mast cells.
    Frank SP; Thon KP; Bischoff SC; Lorentz A
    Mol Immunol; 2011 Oct; 49(1-2):353-8. PubMed ID: 21981832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.